Boston Scientific May Pull Synergy Stent Out Of India

Bloomberg reports that Boston Scientific (NYSE:BSX) is considering withdrawing its high-end Synergy stent from India due to price concerns. Company representatives met with the National Pricing Authority yesterday seeking a higher price. The regulator stated that an upward revision, if approved, would not be instituted until February, however.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.